Gilead's Trials on Remdesivir to End in May; Worries on Access to the Drug Now Arises

Medicine & Technology May 15, 2020

The trials for Gilead's remdesivir is said to end in May. With the drug only being used for COVID-19 patients under the emergency use authorization, many worry about their access to the drug that has proved to be helpful against the coronavirus. Click the link above to learn more.

Remdesivir First FDA-Approved Drug for COVID-19 Could Cost up to $4,500 Despite Costing Just $9.32 to Manufacture

May 07, 2020

Remdesivir is now finally the first drug to be approved by the US FDA to treat COVID-19. However, controversy has started regarding its price. Experts say that is could cost up to $4,500 despite requiring just $9.32 to make. Click the link to read more.

Remdesivir, Direct-Acting Antiviral: Highly Potent in Inhibiting Coronavirus Replication, Study Says

Apr 22, 2020

Scientists from Canada have revealed how Remdesivir from Gilead Sciences can stop the replication of coronavirus. Previous studies have also shown how it was effective in stopping the replication of the Ebola and MERS-CoV viruses.

Remdesivir Vs Coronavirus: Nearly All Patients Discharged in Less Than A Week, Only 2 Died, Phase 3 Trials Showed

Apr 16, 2020

Remdesivir, the drug candidate of Gilead Sciences showed promising results from its two phase three trials. Experts believe the drug would most likely lead to fast approvals by the Food and Drug Administration as long as proven safe and effective.

Two-Thirds of Severely Ill Coronavirus Patients Recovered With Remdesivir But Experts Remain Doubtful

Apr 13, 2020

The Antiviral, Remdesivir from Gilead Sciences, sparks hope as a new study revealed two-thirds of severely ill coronavirus patients improved after the use of the drug. Although the results of the study seem promising, many experts believe that proof of the drug's effectivity is still lacking. To answer important questions, more studies need to be conducted on a wide variety of patients. Click the link above to find out more.

Promising COVID-19 Treatment Fails Initial Testing

Mar 20, 2020

Hopes have risen for the antiviral medicines that would help patients recover from coronavirus (COVID-19).